摘要
背景:新生肿瘤中癌细胞增殖加剧,导致低氧微环境的发生,这与患者预后不良有关,因为这些应激条件。离子增强肿瘤细胞的迁移、侵袭和转移能力。这些变化与低氧诱导因子(HIFs,主要是HIF1α)的诱导和表达的增加有关。N个靶基因,包括Caveolin-1(CAV 1)。我们组的结果表明,CAV 1在转移性癌细胞中的表达促进了细胞在体外的迁移/侵袭,并促进了在体内的转移。src家族激酶依赖酪氨酸-14磷酸化的方式。在这里,我们评估了低氧诱导的CAV 1表达是否需要低氧依赖性迁移和侵袭。<生>细胞( cell的名词复数 ). 方法:将B16-F10小鼠黑色素瘤和HT 29(US)结肠腺癌细胞暴露于低氧(1%O2)中。Western印迹法检测CAV 1的表达。内源性CAV 1和HIF1α被击倒使用不同的shRNA结构。用Boyden箱法和Matrigel法分别评价细胞迁移和侵袭性。 结果:缺氧可使B16-F10和HT 29(US)细胞的CAV 1蛋白水平呈HIF1α依赖性增加。重要的是,这两种肿瘤细胞的低氧依赖性迁移都是团状的。在CAV 1上被击倒了。同样,药物抑制HIF可防止缺氧诱导的B16-F10细胞迁移和侵袭.最后,缺氧诱导的迁移也被src-家族激酶抑制剂4-氨基-5-(4-氯苯基)-7-(对丁基)吡唑啉3,4-dpyrimidine(PP2)是CAV 1磷酸化的抑制剂。 结论:低氧诱导转移癌细胞的迁移和侵袭需要HIF1α依赖性诱导CAV 1的表达和src家族激酶的激活。
关键词: 缺氧,HIF1α,CAV 1表达,Src家族激酶,迁移,侵袭。
Current Molecular Medicine
Title:Hypoxia-Induced Caveolin-1 Expression Promotes Migration and Invasion of Tumor Cells
Volume: 18 Issue: 4
关键词: 缺氧,HIF1α,CAV 1表达,Src家族激酶,迁移,侵袭。
摘要: Background: Exacerbated proliferation of cancer cells in nascent tumors leads to the genesis of a hypoxic microenvironment, which is associated with poor patient prognosis, because these stress conditions enhance migratory, invasive and metastatic capacities of tumor cells. These changes are associated with the induction of the hypoxia-inducible factors (HIFs, mainly HIF1α) and increased expression of target genes, including Caveolin-1 (CAV1). Results from our group have shown that CAV1 expression in metastatic cancer cells promotes cell migration/invasion in vitro and metastasis in vivo in a manner dependent on tyrosine-14 phosphorylation by src family kinases. Here, we evaluated whether hypoxia-induced expression of CAV1 was required for hypoxia-dependent migration and invasion in cancer cells.
Methods: B16-F10 murine melanoma and HT29(US) colon adenocarcinoma cells were exposed to hypoxia (1% O2). CAV1 expression was evaluated by western blotting. Endogenous CAV1 and HIF1α were knocked-down using different shRNA constructs. Cell migration and invasion were evaluated in Boyden Chamber and Matrigel assays, respectively.
Results: We observed that hypoxia increased CAV1 protein levels in a HIF1 α- dependent manner, in B16-F10 and HT29(US) cells. Importantly, hypoxia-dependent migration of both tumor cell lines was blocked upon CAV1 knock-down. Likewise, pharmacological inhibition of HIF prevented hypoxia-induced migration and invasion in B16-F10 cells. Finally, hypoxia-induced migration was also blocked by the src-family kinase inhibitor 4-amino-5-(4-chloro-phenyl)-7-(t-butyl) pyrazolo3,4-dpyrimidine (PP2), an inhibitor of CAV1 phosphorylation.
Conclusion: Hypoxia induced migration and invasion of metastatic cancer cells require HIF1α-dependent induction of CAV1 expression and src family kinase activation.
Export Options
About this article
Cite this article as:
Hypoxia-Induced Caveolin-1 Expression Promotes Migration and Invasion of Tumor Cells, Current Molecular Medicine 2018; 18 (4) . https://dx.doi.org/10.2174/1566524018666180926163218
DOI https://dx.doi.org/10.2174/1566524018666180926163218 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Survey of Functional Activities of Alpha-fetoprotein Derived Growth Inhibitory Peptides: Review and Prospects
Current Protein & Peptide Science Patent Selections
Recent Patents on Anti-Infective Drug Discovery Clinical Trials of Targeted Alpha Therapy for Cancer
Reviews on Recent Clinical Trials Tumor Intracellular Redox Status and Drug Resistance-Serendipity or a Causal Relationship?
Current Pharmaceutical Design Omega-3 Fatty Acid Treatment Combined with Chemotherapy to Prevent Toxicity, Drug Resistance, and Metastasis in Cancer
Current Drug Targets New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design The Effects of Vitamin C on Adriamycin-Induced Hypercholesterolemia in Rat
Current Nutrition & Food Science CYP17 Inhibitors for Prostate Cancer Treatment – An Update
Current Medicinal Chemistry Recurrent Scalp Lesions from Glioblastoma: Case Report and Literature Review
Current Cancer Therapy Reviews The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Current Pharmaceutical Design Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway
Clinical Cancer Drugs P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Current Neuropharmacology Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals Intrinsic Disorder in Male Sex Determination: Disorderedness of Proteins from the Sry Transcriptional Network
Current Protein & Peptide Science Role of Dendritic Cells in HIV-Immunotherapy
Current HIV Research CD147 Interacts with NDUFS6 in Regulating Mitochondrial Complex I Activity and the Mitochondrial Apoptotic Pathway in Human Malignant Melanoma Cells
Current Molecular Medicine Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Tamarind Inhibits Solar-Simulated Ultraviolet Radiation-Induced Suppression of Recall Responses in Humans
Letters in Drug Design & Discovery Osteoprotegerin and Diabetes-Associated Pathologies
Current Molecular Medicine